-
REAL-WORLD HEALTHCARE RESOURCE UTILIZATION AND COSTS FOLLOWING MAVACAMTEN INITIATION IN US PATIENTS WITH OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
Aug 11, 2026, 17:16 PM -
HYPERTENSIVE DISORDERS OF PREGNANCY IN HUNGARY: TRENDS IN INPATIENT UTILISATION FROM A NATIONWIDE ADMINISTRATIVE DATABASE (2010-2025)
Aug 11, 2026, 17:16 PM -
CONCEPTUALIZING AND ASSESSING REAL OPTION VALUE FOR HEALTH TECHNOLOGY ASSESSMENT: QUALITATIVE INSIGHTS FROM SAUDI ARABIA
Aug 11, 2026, 17:16 PM -
INVESTIGATION OF THE BENEFIT OF USING AN OS-PROGNOSTIC BIOMARKER FOR EARLY DECISION MAKING IN ONCOLOGY
Aug 11, 2026, 17:16 PM -
UNTREATED RISK OF HOSPITALIZATION AND DEATH AMONG HIGH-RISK PATIENTS WITH MILD-TO-MODERATE COVID-19 IN THE UNITED STATES: A SYSTEMATIC LITERATURE REVIEW UPDATE
Aug 11, 2026, 17:16 PM -
PATIENT EXPERIENCE WITH BLADDER-SPARING THERAPY IN MUSCLE-INVASIVE BLADDER CANCER: A TARGETED LITERATURE REVIEW
Aug 11, 2026, 17:16 PM -
ECONOMIC EVALUATION OF PREVENTING RSV IN GUATEMALAN INFANTS THROUGH MATERNAL BIVALENT RESPIRATORY SYNCYTIAL VIRUS STABILIZED PREFUSION F (RSVPREF) VACCINATION: A COST-EFFECTIVENESS STUDY
Aug 11, 2026, 17:16 PM -
THE SOCIOECONOMIC BURDEN OF IDH-MUTANT GRADE 2 GLIOMA: QUANTIFYING PATIENT AND CAREGIVER PRODUCTIVITY LOSSES IN SPAIN
Aug 11, 2026, 17:16 PM -
A MULTI-COUNTRY SURVEY EXAMINING PAYER AND HTA EXPERT PERCEPTIONS OF DECISION UNCERTAINTY
Aug 11, 2026, 17:16 PM -
ENVIRONMENTAL IMPACT ASSESSMENT FOR TOTAL KNEE REPLACEMENT CARE PATHWAY AND SUBSEQUENT PROSTHETIC JOINT INFECTION
Aug 11, 2026, 17:16 PM -
MANAGING MFN UNCERTAINTY: EUROPEAN RESPONSES AND IMPLICATIONS FOR PRICING AND ACCESS STRATEGY
Aug 11, 2026, 17:16 PM -
COMPARATIVE EFFICACY, HTA ACCEPTABILITY AND ACCESS DIVERGE FOR NEW LUPUS NEPHRITIS THERAPIES IN MOROCCO
Aug 11, 2026, 17:16 PM -
PATIENT DEMOGRAPHICS, TREATMENT, AND QUALITY OF LIFE IN MULTIPLE MYELOMA: A REAL-WORLD SURVEY IN EUROPE
Aug 11, 2026, 17:16 PM -
HEALTHCARE RESOURCE UTILIZATION AND COSTS IN MYASTHENIA GRAVIS AND GENERALIZED MYASTHENIA GRAVIS IN FRANCE: RELIEF, A CLAIMS-BASED STUDY
Aug 11, 2026, 17:16 PM -
EVALUATING THE TOTAL MEDICAL COSTS OF G-CSF PROPHYLAXIS VERSUS NON-PROPHYLAXIS IN SACITUZUMAB GOVITECAN-TREATED BREAST CANCER PATIENTS IN ASIA
Aug 11, 2026, 17:16 PM -
REIMBURSEMENT UNDER UNCERTAINTY: HOW EUROPEAN HTA ORGANISATIONS MANAGE EVIDENCE GAPS IN ONCOLOGY — A CASE STUDY OF PARP INHIBITORS
Aug 11, 2026, 17:16 PM -
THE SOCIOECONOMIC CONSEQUENCES OF CANCER FOR PATIENTS - ACTIONS NEEDED AND FEASIBLE
Aug 11, 2026, 17:16 PM -
A NEW VALUE SET, AN OLD QUESTION: DISEASE-SPECIFIC UTILITY MEASURES IN NICE TECHNOLOGY APPRAISALS AND THE IMPLICATIONS OF THE NEW UK EQ-5D-5L VALUE SET
Aug 11, 2026, 17:16 PM -
A MINIMUM PERFORMANCE-REPORTING STANDARD FOR AI IN SYSTEMATIC LITERATURE REVIEW IN ABSTRACTS PRESENTED IN ISPOR
Aug 11, 2026, 17:16 PM -
THE KIDS' PROS MAY NOT BE ALRIGHT: NOVEL METHODS FOR ASSESSING THE SUITABILITY OF EXISTING PEDIATRIC PROS FOR USE WITH CHILDREN, AND DATA TO SUPPORT IMPROVED WORDING AND DESIGN
Aug 11, 2026, 17:16 PM
